C-reactive protein is a mediator of cardiovascular disease

Area of Science:

• Biochemistry
• Cardiology
• Immunology

Background:

• C-reactive protein (CRP) has been recognized as a predictor of cardiovascular events and mortality.
• Emerging evidence shows CRP is present in atherosclerotic lesions and initiates pathogenic pathways.
• This suggests CRP is actively involved in atherosclerosis, not just an indicator.

Purpose of the Study:

• To review the evolving understanding of C-reactive protein's role in cardiovascular disease.
• To highlight the shift from CRP as a risk marker to a pathogenic factor.
• To emphasize the potential of targeting CRP for therapeutic interventions.

Main Methods:

• Literature review of experimental data on CRP in atherosclerosis.
• Analysis of studies investigating CRP's role in atherogenic pathways.
• Synthesis of evidence supporting CRP's involvement in disease pathogenesis.

Main Results:

• C-reactive protein is abundant in atherosclerotic lesions.
• CRP initiates key pathogenic pathways contributing to atherogenesis.
• Data support CRP's direct role in the development of cardiovascular disease.

Conclusions:

• C-reactive protein is a direct participant in atherosclerotic cardiovascular disease pathogenesis.
• The paradigm has shifted, viewing CRP as more than just a risk indicator.
• Inhibiting CRP activity presents a novel therapeutic strategy for atherosclerosis prevention.